EPM speaks to the Life Science business of Merck to learn about the company's initiative to implement a sustainability framework across its entire R&D network.
Ian and Reece are back, though they might be tripping over and getting their words muddled up, they talk about Covid-19 vaccine approvals, the EU's pandemic predicament and why Trump is back in the news.
Ian and Reece are back to discuss more news related to the pandemic, as well as another potential re-organisation in the NHS, investment in the UK life sciences sector and another report surrounding the digitisation of healthcare.
EPM speaks to Marcus Michel, CEO of ACG Group’s Engineering Division in Mumbai, India about the biggest industry challenges, his love of technology and the effect Covid-19 has had on business.
Hannah Bailey, business development director of Intoware, explains how digitalisation is helping pharma manufacturers meet digital workflow challenges.
EPM speaks to Spirax Sarco to understand the role steam systems play in pharma and how the company can help improve sustainability throughout the industry.
EPM speaks to Lonza to learn about how to ensure good bioavailability across compounds and which therapy areas are benefitting from targeted drug delivery.
Sahana Mollah, senior manager, Global BioPharma Collaboration & CE Tech Marketing at SCIEX looks at how antibody variants are helping researchers develop new medicines.
EPM speaks to Sophie Walton, group director of Academic Engagement, CPI, to learn about the Northern BioAccelerator Partnership, which was set up to stimulate investment in the North East’s bioscience sector.
Marc Brown, Jon Lenn and Charles Evans, from MedPharm, discuss the latest industry innovations, the benefits of automation and mitigating the risk of product failure in the development of topical products.
EPM speaks to Shorla Pharma’s CTO Orlaith Ryan about how the company is aiming to be a strong contender in the oncology market through therapies designed for women and children.
